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ORIGINAL RESEARCH

Micronutrient Deﬁciency Independently Predicts Time to Event in
Patients With Heart Failure
Terry A. Lennie, PhD, RN, FAAN; Christina Andreae, PhD, RN; Mary Kay Rayens, PhD; Eun Kyeung Song, PhD, RN; Sandra B. Dunbar, DNS,
RN, FAAN; Susan J. Pressler, PhD, RN, FAAN; Seongkum Heo, PhD, RN; JinShil Kim, PhD, RN; Debra K. Moser, PhD, RN, FAAN

Background-—Dietary micronutrient deﬁciencies have been shown to predict event-free survival in other countries but have not
been examined in patients with heart failure living in the United States. The purpose of this study was to determine whether
number of dietary micronutrient deﬁciencies in patients with heart failure was associated with shorter event-free survival, deﬁned
as a combined end point of all-cause hospitalization and death.
Methods and Results-—Four-day food diaries were collected from 246 patients with heart failure (age: 61.512 years; 67% male;
73% white; 45% New York Heart Association [NYHA] class III/IV) and analyzed using Nutrition Data Systems for Research.
Micronutrient deﬁciencies were determined according to methods recommended by the Institute of Medicine. Patients were followed
for 1 year to collect data on all-cause hospitalization or death. Patients were divided according to number of dietary micronutrient
deﬁciencies at a cut point of ≥7 for the high deﬁciency category versus <7 for the no to moderate deﬁciency category. In the full sample,
29.8% of patients experienced hospitalization or death during the year, including 44.3% in the high-deﬁciency group and 25.1% in the
no/moderate group. The difference in survival distribution was signiﬁcant (log rank, P=0.0065). In a Cox regression, micronutrient
deﬁciency category predicted time to event with depression, NYHA classiﬁcation, comorbidity burden, body mass index, calorie and
sodium intake, and prescribed angiotensin-converting enzyme inhibitors, diuretics, or b-blockers included as covariates.
Conclusions-—This study provides additional convincing evidence that diet quality of patients with heart failure plays an important
role in heart failure outcomes. ( J Am Heart Assoc. 2018;7:e007251. DOI: 10.1161/JAHA.117.007251.)
Key Words: diet • heart failure • nutrition • risk factor • survival analysis
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S

odium has been the primary nutrient of interest in heart
failure management for >60 years because of its relationship with ﬂuid retention, symptoms, and hospitalizations.1,2
Nevertheless, nutrition in heart failure is recognized to extend
beyond sodium3 and may be equally important for management as drugs and devices.4 Accumulating evidence suggests
that micronutrient deﬁciencies are common in patients with
heart failure,5–10 but less evidence shows the relationship of

From the College of Nursing, University of Kentucky, Lexington, KY (T.A.L.,
M.K.R., D.K.M.); Division of Nursing Science, Department of Medical and Health
Sciences, Link€
oping University, Link€oping, Sweden (C.A.); Department of
Nursing, College of Medicine, University of Ulsan, Korea (E.K.S.); Emory
University, Atlanta, GA (S.B.D.); Indiana University, Indianapolis, IN (S.J.P.);
College of Nursing, University of Arkansas for Medical Sciences, Little Rock, AR
(S.H.); Gachon University College of Nursing, Incheon, Korea (J.K.).
Correspondence to: Terry A. Lennie, PhD, RN, FAAN, College of Nursing,
University of Kentucky, 751 Rose Street, Lexington, KY 40536-0232. E-mail:
tlennie@uky.edu

micronutrient deﬁciencies to heart failure outcomes.11–13 A
recent study by Song and Kang14 demonstrated that micronutrient deﬁciencies independently predicted cardiac event-free
survival in patients with heart failure living in South Korea.
Patients’ risk of hospitalization or death increased by 14% for
each additional micronutrient that was deﬁcient in the diet. The
purpose of this study was to determine whether micronutrient
deﬁciencies in patients with heart failure living in the United
States were associated with similar risks.
Speciﬁc aims were (1) to determine dietary nutritional
status based on 4-day food diaries; (2) to examine associations between nutritional deﬁciencies and demographic and
clinical variables; and (3) to assess whether the degree of
nutritional deﬁciency was predictive of time to event (allcause hospitalization or death), controlling for demographic
and clinical covariates.

Received May 14, 2018; accepted July 9, 2018.
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The data, analytic methods, and study materials will be made
available to other researchers for purposes of reproducing the
results or replicating the procedure by the corresponding
author upon reasonable request.
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Measures
Demographic factors

What Is New?
• High dietary micronutrient deﬁciency was a strong independent predictor of 1-year hospitalization or death in a
sample of patients from the United States.
• Most common dietary nutrient deﬁciencies were in calcium,
folate, magnesium, zinc, and vitamins C, D, E, and K.
• Patients with comorbid depressive symptoms may be particularly vulnerable to dietary micronutrient deﬁciencies.
• Patients with high body mass indexes were equally likely to
have diets high in micronutrient deﬁciencies.

What Are the Clinical Implications?
• Nutritional deﬁciency is an important risk factor for
hospitalization and death in patients with heart failure.
• Patients should be assessed for potential dietary deﬁciencies regardless of body mass index.
• The wide range of micronutrient deﬁciencies suggests
that a focus on promoting a varied diet is necessary
to prevent patients having multiple micronutrient
deﬁciencies.
• Patients at high risk for dietary micronutrient deﬁciencies
may beneﬁt from consultation with a dietitian.

Data on age, sex, and race were collected by patient
interview. Body mass index (BMI) deﬁned as weight in
kilograms divided by height in square meters (kg/m2) was
calculated for inclusion in the analysis.

Heart failure classiﬁcation
The NYHA functional classiﬁcation was used to summarize
heart failure severity. This variable was dichotomized into III/
IV versus I/II before analysis. NYHA functional class was
determined by careful patient interview using a standardized
form. Reproducibility both among different raters (interrater
reliability) and for the same rater (intrarater reliability) at each
site was ensured by training raters and testing them with
sample patients until interrater agreement was 100%.

Prescription drugs
Prescribed medication regimens (ie drugs, doses, frequencies)
were obtained from patient interview and medical record
review to conﬁrm patient report. Four indicator variables were
created, one each for angiotensin-converting enzyme inhibitor
prescription (yes/no), angiotensin receptor blocker prescription (yes/no), diuretic prescription (yes/no), and b-blocker
prescription (yes/no).

Downloaded from http://ahajournals.org by on March 25, 2019

Study Design and Population

Comorbidities

This multicenter longitudinal study included 274 patients
with heart failure recruited from 3 heart failure clinics
afﬁliated with academic medical centers located in Georgia,
Indiana, and Kentucky. Inclusion criteria were (1) conﬁrmed
diagnosis of heart failure with either reduced or preserved
ejection fraction, (2) New York Heart Association (NYHA)
classiﬁcation I–IV, (3) stability on medication regimen for
3 months before enrollment, (4) no history of hospitalization
in the 3 months before enrollment, (5) ability to speak and
write English, and (6) no obvious cognitive impairment.
Exclusion criteria were (1) status 1 on a cardiac transplant
list or the presence of a left ventricular assist device;
(2) end-stage kidney (on dialysis), liver, or pulmonary
disease; (3) active cancer treatment or cancer likely to cause
death within 12 months; and (4) any health condition that
required dietary restrictions other than those for heart
failure or diabetes mellitus. Eight participants withdrew and
14 participants whose average 4-day kcal intake from food
diary was <40% of estimated energy requirements were
excluded from the analysis.10 Another 6 participants were
omitted from this analysis because they were missing either
days of follow-up or a depressive symptoms score (ie, Beck
Depression Inventory II [BDI-II]). The ﬁnal sample comprised
246 patients.

Comorbidity burden was determined by the Charlson Comorbidity Index interview format.15 Total scores could range from
1 to 34. Reliability and validity have been demonstrated.15,16
The total comorbidity score was used in the analysis.

DOI: 10.1161/JAHA.117.007251

Depressive symptoms
The BDI-II17–19 was used to assess level of depressive
symptoms in the sample. This 21-item instrument measures
the degree of depressive symptoms, such as pessimism,
agitation, and loss of energy, with most items scored on a 0 to
3 scale; 2 of the items are scored on a 0 to 6 scale and then
rescaled to range from 0 to 3 before inclusion in the total.
Higher scores on each item indicate greater depressive mood,
and the total score is the sum of all 21 items. Scores >13 are
indicative of clinically signiﬁcant depressive symptoms.20
Cronbach’s a for this sample is 0.91.

Laboratory values
Blood was drawn for NT-proBNP (N-terminal probrain natriuretic peptide), serum sodium, and uric acid during the
baseline visit to the clinical research center at each site.
Serum sodium and uric acid were measured at each
participating site’s hospital laboratory using standard laboratory methods. Blood for NT-proBNP was shipped to the
Journal of the American Heart Association
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Seattle Heart Failure Model
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The Seattle Heart Failure Model score was included in the
analysis to control for covariates associated with event-free
survival. The model score was calculated using the Windows
version of the Seattle Heart Failure Model calculator for the
web (https://depts.washington.edu/shfm/?width=1366&he
ight=768) and included age, sex, ischemic origin of heart
failure, systolic blood pressure, ejection fraction, medication
(angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, aldosterone blocker, b-blocker, statins, diuretic
type and daily dose, and allopurinol), laboratory values (serum
sodium, total cholesterol, hemoglobin, percent lymphocytes,
and uric acid), body weight, and NYHA functional class. The
presence of an implantable device (pacemaker, implantable
cardioverter-deﬁbrillator, or cardiac resynchronization therapy) was also included.21 Default values for systolic blood
pressure (120 mm Hg) and lymphocyte percentage (24%)
were used because they were not collected at baseline. Data
on presence of left bundle-branch block and QRS >150 ms
were also missing and subsequently not included in score
calculation. Seattle Heart Failure Model scores are strong
predictors of hosptializtion22 and both shorter (1-year) and
longer (2- and 3-year) survival.23

the recommended daily allowance has been established. Diet
deﬁciency for these micronutrients was deﬁned as intake
<50% of the recommended daily allowance for each micronutrient. The number of micronutrient deﬁciencies was summed.
Because this variable was skewed to the right, we created a
binary variable using the cut point of ≥7 for the high deﬁciency
category. This value was chosen because 25% of the sample
had a score at or above this level; this type of dichotomy has
been used previously with skewed clinical predictors of heart
failure outcomes.25 Participants with fewer micronutrient
deﬁciencies were classiﬁed as no to moderate deﬁciency.

Event-free survival
Patients kept a diary of all hospitalizations and were called
monthly by a trained research assistant to obtain hospitalization data for 1 year following baseline data collection using a
well-validated life history method.26,27 All hospitalizations
were veriﬁed by medical record review. When patient recall
varied from the medical records, the medical record was
considered the gold standard. With patient or family assistance, hospital discharge and other medical records were
obtained from identiﬁed sources of care outside of the studysite healthcare systems. We have >20 years of experience
collecting these data and have successfully obtained hospitalization data on all rural patients in our current and previous
studies.28–41 All-cause mortality data (date and cause of
death) were collected for 1 year from baseline by a combination of medical record review, electronic clinical record
review, interviews with patients’ healthcare providers and
family, and public death record review.30,31,40–43

Number of nutritional deﬁciencies

Procedure

Nutritional intake averaged over the 4 days was determined
using Nutritional Data Systems-R software (Nutrition Coordinating Center, University of Minnesota). Dietary adequacy of
17 micronutrients (11 vitamins and 6 minerals) was deﬁned
according to recommendations outlined by the Food and
Nutrition Board of the Institute of Medicine.24 For 7 micronutrients (magnesium, folate, vitamin B6, niacin, thiamin,
riboﬂavin, and phosphorus), sufﬁcient population-based data
were available for the Food and Nutrition Board to establish
parameters to calculate a probability ratio that a patient’s diet
was habitually high or low in a micronutrient based on a 4-day
food diary. A ratio < 1 indicated a high probability that the
patient’s diet was habitually low in that micronutrient. For 8
micronutrients (calcium, iron, selenium, zinc, and vitamins B12,
C, D, and E), diet adequacy was based on estimated average
requirement because probability formulas have not been
established. Micronutrient deﬁciency was deﬁned as intake
below the estimated average requirement for each micronutrient. For 2 vitamins (vitamin K and pantothenic acid), only

The study was approved by the institutional review board at
each site before start of study. All participants gave signed
informed consent before data collection, which occurred
between June 2006 and March 2009. Patients were referred
by nurse practitioners to a research assistant who veriﬁed
eligibility. For those who agreed to participate, appointments
were made by a trained research nurse to visit them in their
homes to complete all questionnaires and to provide the
equipment (food diary, digital food scale, food portion models,
and food portion pictures) and detailed instructions for ﬁlling
out the 4-day food diary. Patients did a return demonstration
so investigators could verify understanding and provide an
opportunity to clarify procedures. Patients recorded all foods,
liquids, and dietary supplements consumed for 1 weekend day
and 3 weekdays. The research nurse called the morning of the
ﬁrst recording day to again verify understanding and answer
any questions about recording the food diary. Patients who
consumed packaged foods were instructed to bring the empty
packages with them with the food diary. The morning

DOI: 10.1161/JAHA.117.007251
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primary site. Plasma levels of NT-proBNP were measured by
the core laboratory at the primary site clinical research center
using a commercially available ELISA kit. Assays were run in
duplicate, and when the inter- and intra-assay coefﬁcients of
variation (reﬂecting accuracy and reproducibility) were unacceptable (coefﬁcient of variation >10%), the assay was
redone.
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Data Analysis
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Descriptive statistics, including means and standard deviations
or frequency distributions, were used to summarize the study
variables. Both arithmetic and geometric means and their 95%
conﬁdence intervals (CIs) were used to summarize micronutrient intake. Comparisons between the no- to moderatedeﬁciency group and the high-deﬁciency group were accomplished using the 2-sample t test or v2 test of association.
Although other clinical variables had distributions that were
approximately normal, NT-proBNP was log-transformed before
group comparison because of a right-skewed distribution.
Predictors of event-free survival were assessed using Cox
regression. Several Cox regression models were run, and the
proportional hazards assumption was tested by introducing
time-dependent covariates in the ﬁtted main effects models.
The ﬁrst model, based on the full sample (N=246), included
nutrient deﬁciencies as the predictor of event-free survival, with
race, total comorbidities, depressive symptoms, sodium
intake/1000 kcal, and Seattle Heart Failure Model score as
covariates. The second model included all the same variables
plus log-transformed NT-proBNP as an additional covariate. The
sample size for this model was smaller (n=222) because NTproBNP was not available for all patients. Third, because kcal
intake was lower in the high-deﬁciency group, we ran a
sensitivity analysis with kcal/kg added to the Cox model that
included the full sample. For each Cox regression, the
proportionality test evaluated whether the required condition
of proportional hazards was met, whereas variance inﬂation
factors were used to assess the presence of multicollinearity.
Finally, the bivariate association between deﬁciency group
status and time to event (all-cause hospitalization or death) was
evaluated with the log rank test and graphed using a Kaplan–
Meier plot. Data analysis was done using SAS v9.3 (SAS
Institute); an a level of 0.05 was used throughout.
DOI: 10.1161/JAHA.117.007251

Results
On average, the participants were aged 61 years (range: 24–
97 years; see Table 1). They were predominantly male and
white, with NYHA classiﬁcation of I or II. Most participants
were prescribed angiotensin-converting enzyme inhibitors,
diuretics, and/or b-blockers; a ﬁfth were prescribed an
angiotensin receptor blocker. The mean comorbidity score
was 3 (range: 1–8). The majority of participants were
overweight or obese (24% normal weight, 29% overweight,
24% obese class 1, and 23% obese class 2 or 3).44
The median number of micronutrient deﬁciencies in
patients’ diets was 4 (range: 0–14). Comparing those with
high micronutrient deﬁciency to those with no to moderate
deﬁciency, the high-deﬁciency group was younger, more likely
to be black or other minority, and other minority (Asian,
Hispanic, or Native American) had higher depressive symptoms scores. The percentage of participants in the highdeﬁciency group was relatively evenly distributed across BMI:
22% were normal weight, 29% were overweight, 26% were
obese class 1, and 23% were obese class 2 or 3. Those in the
high-deﬁciency group had lower kcal and sodium intake than
the no- to moderate-deﬁciency group. The 2 groups also
differed on the ratio of sodium per 1000 kcal, with the
average for the high-deﬁciency group being 12% higher than
the no- to moderate-deﬁciency group. The 2 deﬁciency
groups did not differ by sex; NYHA classiﬁcation group; left
ventricular ejection fraction <50%; serum sodium, uric acid, or
NT-proBNP; prescribed angiotensin-converting enzyme inhibitors, angiotensin receptor blocker, diuretics, or b-blockers;
number of comorbidities; BMI; or Seattle Heart Failure Model
score.
The summary of deﬁciency status for each micronutrient is
given in Table 2. The table entries are ordered from greatest
percentage of participants with a micronutrient deﬁciency to
least, with recommended daily micronutrient requirements for
men and women aged 51 to 70 provided as reference values.
Both the arithmetic and geometric means are given for the
level of consumption of each micronutrient, along with the CIs
for each. The micronutrients most often deﬁcient included
calcium, magnesium, and vitamins D and E, whereas phosphorus, niacin, thiamin, and riboﬂavin were less frequently
deﬁcient.
The Cox regression model to assess predictors of time to
event was signiﬁcant overall (likelihood ratio, v2=26.6,
P<0.001). With demographic and clinical variables included
as covariates, number of comorbidities, depressive symptoms, and high micronutrient deﬁciency status were signiﬁcant predictors of time to all-cause hospitalization or death,
whereas race, BMI, sodium intake per 1000 kcal, comorbidity
score, and Seattle Heart Failure Model score were not
signiﬁcant (model 1; Table 3). For every 5-U increase in BDI-II
score, the hazard of having a hospitalization or death
Journal of the American Heart Association
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following completion of food diary, patients visited the clinical
research center at each site for measurement of height and
weight and for review of the food diary. A dietician at each site
carefully reviewed the food diaries with the patients, and
spouses if appropriate, to clarify information regarding
ingredients, verify portion sizes, and obtain any missing data
(eg, preparation methods). The interviews averaged 30 to
45 minutes. The completed food diaries from all sites were
entered into the Nutritional Data Systems-Research software
package (Nutrition Coordinating Center, Minneapolis, MN) at
the primary site by a trained research assistant. Data entry
was veriﬁed by the primary investigator (T.A.L.). Patients, or
family members if patients were not available, were followed
for 1 year by monthly phone calls to collect data on
hospitalizations and mortality. Data were veriﬁed by reviewing
hospital records.
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Table 1. Sociodemographic and Clinical Characteristics of the Study Sample by Micronutrient Deﬁciency Status, With Group
Comparisons Using 2-Sample t Tests or v2 Tests of Association
Micronutrient Deﬁciency Status

Age,* y

Full Sample (N=246)

No to Moderate Deﬁciency (n=185)

High Deﬁciency (n=61)

P Value

61.4 (12.0); 24–97

62.6 (12.1); 32–97

57.9 (11.1); 24–83

0.007

164 (67)

126 (68)

38 (62)

Sex
Male, n (%)

0.40
0.001

Race, n (%)
White

180 (73)

145 (78)

35 (57)

Black or other minority

66 (27)

40 (22)

26 (43)

NYHA classification, n (%)

0.22

I/II

133 (54)

104 (57)

29 (48)

III/IV

112 (46)

80 (43)

32 (52)

LVEF <50%, n (%)

212 (86)

160 (86)

52 (85)

0.81

Serum sodium, mmol/dL*

138.9 (2.4); 129–145

138.9 (2.4); 129–145

139.2 (2.5); 132–145

0.38

Downloaded from http://ahajournals.org by on March 25, 2019

Uric acid, mg/dL*

6.9 (1.8); 2.3–16.0

6.9 (1.8); 2.3–16.0

6.9 (1.9); 3.4–12.3

0.83

NT-proBNP, fmol/mL, mean; 95% CI*‡

610.7; 553.0–674.4§

638.7; 567.2–719.2§

529.4; 445.6–628.9§

0.08

ACEI, yes, n (%)

164 (69)

124 (69)

40 (67)

0.71

ARB, yes, n (%)

50 (21)

35 (19)

15 (26)

0.28

Diuretic, yes, n (%)

184 (76)

138 (76)

46 (75)

0.95

Β-blocker, yes, n (%)

216 (89)

160 (87)

56 (92)

0.35

Number of comorbidities*

3.0 (1.8); 1–8

3.0 (1.7); 1–8

2.9 (2.0); 1–8

0.92

BMI*

30.4 (7.1); 16.8–61.3

30.1 (6.9); 16.8–61.3

31.2 (7.4); 18.1–51.3

0.31

Depressive symptoms (BDI-II)*

10.5 (8.3); 0–41

9.8 (8.3); 0–41

12.8 (8.2); 0–38

0.02

Calorie intake*

1852 (639); 716–4363

1970 (656); 716–4363

1493 (417); 775–2870

<0.001

Sodium intake*

3198 (1306); 888–9138

3309 (1353); 888–9138

2861 (1091); 890–6003

0.01

Sodium intake/1000 kcal*

1.8 (0.5); 0.4–3.8

1.7 (0.4); 0.4–3.4

1.9 (0.6); 0.6–3.8

0.005

Seattle Heart Failure Model score*

11.3 (4.6); 2.6–27.4

11.3 (4.7); 2.6–27.4

11.3 (4.3); 3.7–23.4

0.99

Data are shown as mean (SD); range, except as noted. ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BDI-II, Beck Depression Inventory II; BMI,
body mass index; CI, conﬁdence interval; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal probrain natriuretic peptide; NYHA, New York Hospital Association.
*Group comparisons done with 2-sample t test; all other comparisons accomplished using v2 test of association.
‡
Whereas all other study variables were missing for at most 7 participants, this one was missing for 24.
§
As a correction for skewness, a log transformation was used before the group comparison of NT-proBNP; the values shown in the table for this variable are the geometric mean and
corresponding 95% CI.

increased by 15%. Compared with those with no or moderate
micronutrient deﬁciency, those with high deﬁciency had
92% greater hazard of hospitalization for or death from any
cause.
The second model included the demographic and clinical
characteristics of the ﬁrst with the addition of log-transformed
NT-proBNP (model 2; Table 3). The signiﬁcant predictors in this
model included depressive symptoms, NT-proBNP, and deﬁciency status, and the overall model was signiﬁcant (likelihood
ratio, v2=39.5, P<0.001). This model was largely consistent
with the prior model except that number of comorbidities no
longer met the threshold for signiﬁcance, and the sample size
was diminished by 24 (the number of participants for whom NTDOI: 10.1161/JAHA.117.007251

proBNP was not measured). In this model, a 5-point increase in
BDI-II was associated with a 22% increase in the hazard of
hospitalization or death. Those with high micronutrient deﬁciency had double the hazard of all-cause events compared with
the reference group of no to moderate deﬁciency. The hazard
ratio for the log of NT-proBNP suggested that those with
increased values for this measure had greater hazard of
experiencing an event (ie, 2.8 times the hazard for each 1-U
increase in the log of NT-proBNP). For both models, the test of
proportionality was not signiﬁcant (P>0.68 for both), and the
variance inﬂation factors were <1.2 for each independent
variable in the model, suggesting that multicollinearity did not
distort parameter estimates.
Journal of the American Heart Association
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Reference
Variable

Calcium, mg*
Magnesium, mg

†

Untransformed Data

Log-Transformed Data

Micronutrients/Day, Men; Women

% Deﬁcient

Mean (Arithmetic)

95% CI

Mean (Geometric)

95% CI

1.0; 1.2

67.1

862.1

801.5–922.6

747.9

699.1–800.2

420; 320

62.2

301.9

284.6–319.3

275.3

260.9–290.6

Vitamin D, qg‡

15; 15

60.6

9.2

7.9–10.6

5.8

5.1–6.6

Vitamin E, mg*

15; 15

59.4

82.0

44.8–119.2

13.0

10.8–15.6

Zinc, mg*

11; 8

45.5

15.5

14.0–17.0

12.8

11.8–13.8

Vitamin C, mg*

90; 75

39.4

185.8

123.0–248.5

83.7

72.5–96.8

Vitamin K, qg‡

120; 90

29.7

109.4

97.1–121.8

81.5

74.0–89.7

400; 400

27.2

548.7

502.6–594.9

463.7

431.5–498.3

Folate, qg

†

Vitamin B12, qg*

2.4; 2.4

9.4

50.6

4.5–96.7

7.5

6.4–8.7

Pantothenic acid, mg‡

5; 5

4.1

9.7

7.7–11.7

6.7

6.1–7.4

1.7; 1.5

3.3

3.4

2.5–4.3

2.3

2.1–2.5

Vitamin B6, mg
Selenium, qg

†

‡

Iron, mg*
Phosphorus, mg†
Niacin, mg

3

Thiamin, mg†
Riboflavin, mg

†

55; 55

2.0

117.3

110.2–124.4

107.7

102.4–113.4

8; 8

2.0

20.9

16.9–24.8

16.4

15.2–17.6

700; 700

1.6

1200.0

1145.4–1254.6

1129.1

1080.8–1179.6

16; 14

1.6

54.7

33.6–75.9

29.3

26.6–32.1

1.2; 1.1

0.4

4.8

2.3–7.2

2.1

1.9–2.3

1.3; 1.1

0

3.6

2.6–4.5

2.5

2.3–2.7
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CI indicates conﬁdence interval.
*Deﬁciency status based on estimated average requirement.
†
Deﬁciency status based on probability formula.
‡
Deﬁciency status based on <50% recommended daily allowance.

In the sensitivity analysis with kcal/kg added to the fullsample model, deﬁciency status remained a signiﬁcant
predictor of event-free survival (likelihood ratio, v2=4.25,
P=0.039). The CI for the hazard ratio for this predictor was
relatively wide, suggesting increased variability related to the
inclusion of kcal/kg, likely caused by the strong association
between kcal and deﬁciency status. The estimated hazard
ratio for deﬁciency status in this model was 4.87, and the
corresponding 95% CI was 1.08 to 21.89. This model also had
a nonsigniﬁcant proportionality of hazards test (P=0.83), and
the variance inﬂation factors were all <1.7.
In the full sample, 30.1% of patients experienced hospitalization or death during the year. There were 2 deaths (3%) and
25 hospitalizations (41%) in the high-deﬁciency group and 3
(2%) deaths and 44 hospitalizations (24%) in the no/moderatedeﬁciency group. The Kaplan–Meier plot shown in the Figure
provides a graphical representation of the survival distribution
over 1-year follow-up for the 2 micronutrient deﬁciency status
groups. At the end of the yearlong follow-up period, both
groups had >50% surviving event free, so the median eventfree survival time was not estimable; however, the upper
quartile (ie, with 75% surviving event-free) was 193 days (95%
DOI: 10.1161/JAHA.117.007251

CI, 103–303) for the high-deﬁciency group compared with
333 days for the no/moderate deﬁciency group (the lower
95% conﬁdence limit was 225, and the upper conﬁdence limit
was not estimable given the limited number of events in this
group). Mean survival was 266.5 days (SE: 14.1) and
312.9 days (SE: 7.7) for the high- and no/moderatedeﬁciency groups, respectively. In Figure, the survival distribution for the group with high deﬁciency is below than the
group with a more complete diet. Consistent with the
observed difference in distributions, the log rank test for the
group comparison was signiﬁcant (v2=7.6; P=0.0065).

Discussion
Our results using a sample of patients with heart failure
from the United States were similar to those of Song and
Kang14 using a sample of patients from South Korea. The
Kaplan–Meier plot and log rank test demonstrate the
shortest event-free survival was among patients in the high
micronutrient deﬁciency group. Their event hazard was an
alarming 93% higher than patients with fewer micronutrient
deﬁciencies.
Journal of the American Heart Association
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Table 2. Summary of the Micronutrients, Including the Reference of Lowest Micronutrient Intake/Day for Men and Women Aged
51–70 Years, Percentage of the Sample With Deﬁciency, and Arithmetic and Geometric Means and Their Corresponding 95% CIs
(N=246)
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Table 3. Cox Proportional Hazards Models for Time to All-Cause Hospitalization or Death
Variable

Parameter Estimate

SE

HR

95% CI

v2 (P Value)

0.1721

0.2739

1.19

0.69 to 2.03

0.4 (0.39)

Model 1 (N=246)
White
Comorbidity score

0.1142

0.0649

1.21

0.99 to 1.27

3.1 (0.08)

BMI

0.0265

0.0175

1.03

0.99 to 1.06

2.3 (0.13)

BDI-II

0.0324*

0.0131*

1.03*

1.01 to 1.06*

6.1 (0.01)

Sodium intake/1000 kcal

0.1878

0.2567

0.83

0.50 to 1.37

0.5 (0.46)

Seattle Heart Failure Model score

4.326

2.303

0.01

0.00 to 1.21

3.5 (0.06)

0.6519*

0.2621*

1.92*

1.15 to 3.21*

6.2 (0.012)

White

0.2322

3182

1.27

0.68 to 2.35

0.5 (0.46)

Comorbidity score

0.0883

0.0684

1.09

0.96 to 1.25

1.7 (0.20)

BMI

0.0312

0.0201

1.03

0.99 to 1.07

2.6 (0.11)

Have high deficiency
Model 2 (n=222)

BDI-II

0.0427*

0.0143*

1.04*

1.02 to 1.07*

8.9 (0.003)

Sodium intake/1000 kcal

0.1178

0.2548

1.12

0.68 to 1.85

0.2 (0.64)

Seattle Heart Failure Model score

2.206

3.594

9.08

0.01 to 10 416

0.4 (0.54)

NT-proBNP

1.014*

0.2228*

2.76*

1.78 to 4.27*

21 (<0.001)

Have high deficiency

0.7021*

0.2892*

2.02*

1.14 to 3.58*

5.9 (0.01)

BDI-II indicates Beck Depression Inventory-II; BMI, body mass index; CI, conﬁdence interval; HR, hazard ratio; NT-proBNP, N-terminal probrain natriuretic peptide.
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A large number of patients in our study had diets deﬁcient
in calcium, folate, magnesium, zinc, and vitamins C, D, E, and
K. This ﬁnding is similar to a study from Canada10 and 2 from
South Korea14,42 in which the same methods were used to
measure nutritional intake and to deﬁne micronutrient
deﬁciencies. Dietary deﬁciencies in calcium and magnesium
measured by a variety of other methods have also been
reported in studies from the United States,6,45 Brazil,9,46
Ireand,47 and Italy.7 Other commonly reported dietary
deﬁciencies include vitamin D,45–47 vitamin E,6,7,45 and
zinc.7,9,45 This high level of micronutrient deﬁciency is not
conﬁned to adults with heart failure. Diets of age- and sexmatched adults without and with heart failure have been
reported to be comparably poor in several studies.5,7,10
Nevertheless, because patients with heart failure have
enhanced excretion of water-soluble vitamins from diuretic
therapy and evidence of increased metabolic demand,48 these
deﬁciencies may have greater consequences for patients with
heart failure than without.
A cause for the high number of micronutrient deﬁciencies
in older adults may be diet monotony. Eating a varied diet has
been shown to be positively correlated with dietary micronutrient adequacy49—that is, the greater the diversity of foods
in the diet, the less likely there are to be dietary deﬁciencies.
This is particularly true for calcium,49 the micronutrient most
commonly deﬁcient in the diets of patients with heart failure.
DOI: 10.1161/JAHA.117.007251

Anecdotally, we observed that a large number of our patients
consumed the same foods for multiple meals across all
4 days of the food diary. Consistent with this observation are
data suggesting that older adults are more vulnerable to
consuming a monotonous diet because of a decreased drive
to consume varied foods. Pelchat and Shaefer50 compared
food cravings in a group of young adults (mean age: 25 years)
with a group of older adults (mean age: 73 years) before and
while on a 5-day, monotonous, nutritionally complete liquid
diet. The number of cravings was similar in the groups at
baseline. During the diet monotony period, young adults
reported a signiﬁcant increase in the number of cravings,
whereas older adults reported no increase in cravings. The
older adults also indicated a greater liking of the monotonous
diet than the younger adults. Supporting our anecdotal
observation, these results indicate that older adults with
heart failure may be prone to eating diets with limited
variability, placing them at risk for dietary micronutrient
deﬁciencies.
In addition to diet monotony, other factors related to heart
failure and aging may also affect food intake. We conducted a
study comparing heart failure patients’ perceptions of factors
inﬂuencing food intake with a similar group of healthy older
adults.51 Factors with greater impact for patients with heart
failure were dietary restrictions, lack of hunger, feeling full
after eating only a small amount of food, shortness of breath,
Journal of the American Heart Association
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Figure. Kaplan–Meier plot of event-free survival by micronutrient deﬁciency status.
and limited energy. Factors common in both groups, and
presumably more related to aging than heart failure, were
decreased senses of taste and smell.
Patients attempting to follow a very low sodium diet
(<2000 mg) have been reported to develop dietary micronutrient deﬁciencies, suggesting that sodium-restricted diets
may contribute to dietary deﬁciencies.52 Although the group
with higher micronutrient deﬁciency in our study also had
signiﬁcantly lower daily sodium intake, 2 observations suggest
that sodium restriction may not have played a role in dietary
deﬁciencies in our study. First, sodium intake per 1000 kcal
was not an independent predictor of event-free survival.
Second, sodium intake per 1000 kcal was greater in the high
micronutrient deﬁciency group than in the lower deﬁciency
group, indicating that the patients in the higher micronutrient
group were not consuming foods lower in sodium but rather
consuming smaller amounts of food.
The presence of depressive symptoms may be another
factor contributing to micronutrient deﬁciencies. Patients in
the high-deﬁciency group had signiﬁcantly higher depressive
symptom scores than those in the lower deﬁciency group. The
variable of depressive symptoms was the only other one that
DOI: 10.1161/JAHA.117.007251

independently predicted event-free survival in the ﬁrst model
and that remained a signiﬁcant predictor in the second model.
This is consistent with an earlier study of a large sample of
patients in South Korea.42 Patients with depressive symptoms
in that study also had signiﬁcantly more dietary micronutrient
deﬁciencies than patients with low depressive symptoms.
Furthermore, a synergistic negative effect of depressive
symptoms and nutrient deﬁciencies was demonstrated in
that study. Those with the shortest event-free survival were
patients with both depressive symptoms and a high number of
nutrient deﬁciencies, whereas those with the longest survival
had low depressive symptoms and few micronutrient
deﬁciencies.
It is important to highlight the relatively even distribution of
participants in the high-deﬁciency group across BMI categories. This ﬁnding is comparable to that of Shetty et al,53
who reported that the number of dietary micronutrient
deﬁciencies was similar in normal weight and overweight/
obese patients with heart failure. Many screening tools for
malnutrition (eg Geriatric Nutritional Risk Index, Mini Nutrition
Assessment, Nutritional Risk Index) include an anthropometric measure, most commonly BMI.54,55 Although such indexes
Journal of the American Heart Association
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drawn. Calcium and magnesium intake appear to be nearly
universally deﬁcient across multiple countries in Europe,
South America, Asia, and the United States. Although diet
monotony has been clinically observed and anecdotally noted
in our study, it has not been systematically documented in a
research study. Attention to contribution of diet monotony to
micronutrient deﬁciency in future research will help identify
potential interventions that achieve the goal determining ideal
eating patterns to promote optimal health among heart failure
patients of all ages.
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